Endogenous Metabolite (EM) Information
| Endogenous Metabolite (EM) Information | ||||||
|---|---|---|---|---|---|---|
| EM ID |
EM00143
|
|||||
| EM Name |
LysoPC(18:0)
|
|||||
| Synonyms |
1-octadecanoyl-sn-glycero-3-phosphocholine; 1-Stearoyl-sn-glycero-3-phosphocholine; 18:0 Lyso PC; IHNKQIMGVNPMTC-RUZDIDTESA-N; 1-stearoyl-glycero-3-phosphocholine; LPC(18:0/0:0); PC(18:0/0:0); LPC 18:0; 1-Stearoylglycerophosphocholine; lysophosphatidylcholine (18:0); 1-stearoyl-lysophosphatidylcholine; S-LysoPC; LSPC; AC1LAXEH; lysoPC a C18:0; 1-Stearoyl-sn-glycero-3-phosphorylcholine; 1-Octadecanoyllysolecithin; 1-18:0-lysoPC; 1-stearoyl-2-hydroxy-sn-glycero-3-phosphocholine; LysoPC 18:0/0:0
|
|||||
| Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=497299"></iframe>
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C26H54NO7P
|
|||||
| Canonical SMILES |
CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)O
|
|||||
| InChI |
InChI=1S/C26H54NO7P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-26(29)32-23-25(28)24-34-35(30,31)33-22-21-27(2,3)4/h25,28H,5-24H2,1-4H3/t25-/m1/s1
|
|||||
| InChIKey |
IHNKQIMGVNPMTC-RUZDIDTESA-N
|
|||||
| Pharmaceutical Properties | Molecular Weight | 523.7 | Topological Polar Surface Area | 105 | ||
| Heavy Atom Count | 35 | Rotatable Bond Count | 26 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 7 | |||
| PubChem CID | ||||||
| ChEBI ID |
CHEBI:73858
|
|||||
| DT(s) "handling" This EM | CACT | Transporter Info | Carnitine/acylcarnitine translocase | [1] | ||
| References | ||||||
| 1 | Serum metabolomics reveals that arsenic exposure disrupted lipid and amino acid metabolism in rats: a step forward in understanding chronic arsenic toxicity. Metallomics. 2015 Mar;7(3):544-52. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.